Clinical Trial Update: Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 study assessed whether Panax ginseng can enhance the efficacy of antipsychotics in schizophrenia and schizoaffective disorder. The t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Obesity
• Schizoaffective Disorder
• Schizophrenia
• Tardive Dyskinesia

Drugs mentioned

• Panax Ginseng (Panax ginseng)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 1, Phase 2 | Status: COMPLETED